๐ฅ XPeng's Robot Unit Raised $900 Million. It Hasn't Sold a Single IRON.
XPeng's robotics unit raised over $900 million at a $6.3 billion valuation in its first external round โ before the IRON humanoid has shipped a single unit.
XPeng's robotics unit raised over $900 million at a $6.3 billion valuation in its first external round โ before the IRON humanoid has shipped a single unit.
AMD is buying Toronto startup Taalas, which etches AI model weights directly into silicon. Its first test chip ran Llama 3.1 8B at 16,960 tokens/sec โ about 48x a GPU.
Muon Space closed a $250M Series C at a reported $1.5B valuation to industrialize satellite production โ targeting 500 spacecraft a year by 2027, up from the 11 it has flown so far.
OpenAI just let employees cash out $7 billion in stock at an $852 billion valuation โ two months after a confidential SEC filing, and before a single public share trades.
Castelion โ a four-year-old startup founded by SpaceX alumni โ just raised $1B at a $13B valuation to mass-produce Blackbeard, a Mach-5 missile the Navy is buying for about $442,000 apiece.
DeepSeek went out for about $7 billion and investors came back with at least $12 billion, in a Tencent- and CATL-led round ahead of a planned 2027 IPO.
๐ฅ Gigabyte Just Dropped a $400 WOLED Gaming Monitor and It Changes Everything...
The AI chip company Cerebras Systems โ the most prominent challenger to Nvidia's GPU empire โ hit the Nasdaq on Thursday under the ticker CBRS and...
> In 2025, startups discovered AI. In 2026, the winners figured out which tools to use and when. Here's the stack the smartest founders are runni...
Bending Spoons is buying Airtable for $1.285 billion in all cash โ about 89% below the productivity startup's $11.7B pandemic-era peak, and its first deal since going public.
The FDA just approved FAYUVI, the first-ever treatment for Sanfilippo syndrome type A: a one-time gene therapy from Ultragenyx priced at $3.95 million per patient.
Adicet's off-the-shelf CAR-T put 54% of a small lupus trial into remission on a single dose. Then the stock dropped 22%.
Precision Neuroscience closed an oversubscribed $250M Series D at a ~$1B valuation, betting its surface brain implant beats drilling into tissue.